The Food and Drug Administration (FDA) on Friday granted fast-track review to three companies studying psychedelic therapies ...

Trump ordered faster approval of ibogaine for PTSD, backing research and funding that could expand access to psychedelic-based treatments.

(NewsNation) — President Donald Trump signed an executive order Saturday for a speedy review of psychedelic drugs, including ibogaine. Psychedelics like ibogaine are banned under the federal ...

More than 34% of drugs approved by Health Canada through its fast-track accelerated review framework ultimately require the addition of serious safety warnings or removal from the market, claims a new ...